Pien Tze Huang (also spelled as Pien Ze Huang) is a traditional Chinese medicine with a long history. It was first formulated by a royal physician during the Jiajing period of the Ming Dynasty and has a history of over 400 years. As a renowned traditional Chinese patent medicine, Pien Tze Huang is known for its unique medicinal value and high quality, and it has gained a certain level of recognition and market share in the international market.

       According to customs data, the export value of Pien Tze Huang has shown a relatively clear upward trend from 2018 to 2023. The export value increased from USD 30,945,471 in 2018 to USD 55,145,758 in 2023, representing a year-on-year increase of 22.25% compared to 2022, and a total growth of 78.2% over the five years from 2018 to 2023. This growth reflects the increasing influence and demand for Pien Tze Huang in the international market, with its brand value and product recognition continuously improving and attracting more and more overseas consumers and distributors.

       However, the export volume has shown a fluctuating trend overall. It increased from 2,100 kilograms in 2018 to 2,640 kilograms in 2021. However, the export volume remained unchanged in 2022 compared to 2021, and then decreased to 2,253 kilograms in 2023, and further dropped significantly to 1,456 kilograms in 2024. This indicates that while the export value was increasing, the export volume did not maintain synchronous growth and even showed a clear downward trend in later years.

       Looking at the relationship between value and volume, it appears that the export market strategy for Pien Tze Huang may have been adjusted at different stages. In the early period, the company focused on increasing the added value of the product and enhancing brand influence to raise the export price per unit and achieve higher profit margins. In the later period, especially in 2024, facing a significant decline in export volume, the company may have been more inclined to stabilize its market share by adjusting prices and other means. This reflects the company's flexible response strategy under different market conditions.

       As a traditional Chinese medicine, Pien Tze Huang's export market is primarily concentrated in the Asian market, especially in Southeast Asia, where traditional Chinese medicine has a deep cultural foundation and a broad consumer base. It accounts for 99.18% of the total export volume, with major destinations including Hong Kong, China; Indonesia; Thailand; Singapore; and Malaysia. Meanwhile, some emerging markets are gradually emerging, such as Brazil and the United States in the Americas, and Australia, which also has a relatively stable market for traditional Chinese medicine. Among them, the re-export share of the Hong Kong market is at least 20%.

       Due to differences in cultural background and theoretical systems, the promotion of traditional Chinese medicine in the international market still faces many practical difficulties. For example, the theories and practices of traditional Chinese medicine require more scientific validation and international recognition. Moreover, different countries and regions have varying regulations and standards for pharmaceutical products, and traditional Chinese medicine products need more effort and coordination in market access and legal protection. The export market of Pien Tze Huang has experienced complex changes in recent years, and companies need to continuously optimize their business strategies and actively respond to market challenges to achieve sustainable development.

       Overall, the acceptance of traditional Chinese medicine in the international market is continuously increasing, but it also faces challenges in terms of culture, regulations, and other aspects. By strengthening international cooperation and improving product quality and standards, traditional Chinese medicine is expected to gain broader recognition and application in the international market.

       GuoMaoTong, as China's first data company, can provide customs data on imports and exports from over 80 countries since 2010. It is capable of conducting precise online analysis of the distribution of import and export markets, as well as detailed transaction situations of import and export companies, including specific quantity and price analysis, supply cycles, etc. This provides reliable data support for major foreign trade companies and industry consulting firms.

(This article is an original creation by BTD. Please indicate the source when reposting.)